ENOB News and Press, Enochian Biosciences Inc. From 03/14/21

The following slide deck was published by Enochian Biosciences, Inc. in conjunction with this event. For further details see: Enochian Biosciences (ENOB) Presents At H.C. Wainwright Global Life Sciences Conference

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences , a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the upcoming H.C. Wainwright Global Lif...

Express (EXPR) +62% as company lines up new financing.DPW Holdings (DPW) +57% as pre-orders for residential level 2 EV chargers have begun on Amazon.Pingtan Marine Enterprise (PME) +43% on announcing FY 2021 guidance.ZW Data Action Technologies (CNET) +38%. after the company wa...

LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences , a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors on its innovative ...

Drs. Carol Brosgart, Peter Revill and Fabien Zoulim will advise on development of a cure for Hepatitis B LOS ANGELES, July 27, 2020 (GLOBE NEWSWIRE) --  (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious di...

Enochian Biosciences (NASDAQ: ENOB ) is 3.8% lower after hours following its filing to offer up to $50M in shares. More news on: Enochian Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Kiniksa Reports Positive Outcome from 28-Day Clinical Trial Kiniksa Pharmaceuticals Ltd. ( KNSA ) announced that it has received positive data from its COVID-19 treatment trial. This 28 day clinical outcomes data pertains to the open label treatment protocol with mavrilimumab. The compan...

This Is Why Penny Stocks Won’t Lose Their Luster If you’ve ever second-guessed penny stocks , you’re not alone. There are plenty of traders in the stock market today that will avoid these cheap stocks entirely. However, for those who’ve avoided this equity class, t...

Enochian Biosciences (NASDAQ: ENOB ) +277%  on advancement  of potential HIV cure. More news on: Enochian Biosciences Inc., SuperCom Ltd., Chesapeake Energy Corporation, Stocks on the move, , , Read more ...

Thinly traded micro cap Enochian Biosciences (NASDAQ: ENOB ) rockets  292%  premarket on robust volume in reaction to its announcement that it has completed a meeting with the FDA during which there was "strong alignment" between its planned development strategy for ENOB-HV-01 an...